SEI Investments’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-37,407
| Closed | -$6.44M | – | 2708 |
|
|
2021
Q3 | $6.44M | Sell |
37,407
-756
| -2% | -$98.9K | 0.01% | 964 |
|
|
2021
Q2 | $4.78M | Buy |
38,163
+2,304
| +6% | +$291K | 0.01% | 1102 |
|
|
2021
Q1 | $4.86M | Sell |
35,859
-13,921
| -28% | -$1.8M | 0.01% | 1030 |
|
|
2020
Q4 | $6.37M | Sell |
49,780
-1,932
| -4% | -$227K | 0.02% | 859 |
|
|
2020
Q3 | $5.82M | Buy |
51,712
+166
| +0.3% | +$16.5K | 0.02% | 801 |
|
|
2020
Q2 | $4.91M | Buy |
51,546
+3,426
| +7% | +$330K | 0.02% | 866 |
|
|
2020
Q1 | $4.32M | Sell |
48,120
-549
| -1% | -$42.7K | 0.02% | 822 |
|
|
2019
Q4 | $2.64M | Buy |
48,669
+22,669
| +87% | +$1.03M | 0.01% | 1208 |
|
|
2019
Q3 | $1.03M | Sell |
26,000
-3,000
| -10% | -$130K | ﹤0.01% | 1589 |
|
|
2019
Q2 | $1.19M | Sell |
29,000
-600
| -2% | -$24.8K | ﹤0.01% | 1539 |
|
|
2019
Q1 | $1.38M | Sell |
29,600
-11,565
| -28% | -$508K | ﹤0.01% | 1463 |
|
|
2018
Q4 | $2.16M | Buy |
41,165
+14,265
| +53% | +$713K | 0.01% | 1261 |
|
|
2018
Q3 | $1.54M | Buy |
26,900
+26,600
| +8,867% | +$1.31M | 0.01% | 1340 |
|
|
2018
Q2 | $15K | Hold |
300
| – | – | ﹤0.01% | 2891 |
|
|
2018
Q1 | $12K | Sell |
300
-30
| -9% | -$1.27K | ﹤0.01% | 2828 |
|
|
2017
Q4 | $14K | Hold |
330
| – | – | ﹤0.01% | 2710 |
|
|
2017
Q3 | $12K | Buy |
330
+30
| +10% | +$1.04K | ﹤0.01% | 2654 |
|
|
2017
Q2 | $9K | Hold |
300
| – | – | ﹤0.01% | 2620 |
|
|
2017
Q1 | $8K | Hold |
300
| – | – | ﹤0.01% | 2506 |
|
|
2016
Q4 | $8K | Hold |
300
| – | – | ﹤0.01% | 2526 |
|
|
2016
Q3 | $11K | Hold |
300
| – | – | ﹤0.01% | 2392 |
|
|
2016
Q2 | $10K | Buy |
+300
| New | +$9.75K | ﹤0.01% | 2281 |
|
SEI Investments's XLRN Position: Q4 2021 in Review
SEI Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 37,407 shares — an estimated $6.44M sold.
SEI Investments first reported a position in XLRN in Q2 2016 and held it in 22 quarters. The position peaked at $6.44M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- SEI Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- SEI Investments sold 37,407 Acceleron Pharma shares in Q4 2021, an estimated $6.44M.
- SEI Investments first reported a position in Acceleron Pharma in Q2 2016 and held it in 22 quarters.
- SEI Investments's Acceleron Pharma position peaked at $6.44M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on SEI Investments's 13F filing for Q4 2021, filed 14 Feb 2022.